Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity

EMERCE E. , ÇOK İ. , Degim I. T.

TOXICOLOGY LETTERS, cilt.238, ss.90-99, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 238 Konu: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.toxlet.2015.07.003
  • Sayfa Sayıları: ss.90-99


Impurities affecting safety, efficacy, and quality of pharmaceuticals are of increasing concern for regulatory agencies and pharmaceutical industries, since genotoxic impurities are understood to play important role in carcinogenesis. The study aimed to analyse impurities of montelukast chronically used in asthma theraphy and perform genotoxicological assessment considering regulatory approaches.